Mirae Asset Global Investments Co. Ltd. Decreases Stock Holdings in Sanofi (NASDAQ:SNY)

Mirae Asset Global Investments Co. Ltd. decreased its stake in Sanofi (NASDAQ:SNY) by 8.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,773 shares of the company’s stock after selling 948 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Sanofi were worth $525,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC bought a new stake in shares of Sanofi in the second quarter valued at approximately $344,000. Koshinski Asset Management Inc. purchased a new stake in shares of Sanofi during the third quarter worth $211,000. Creative Planning lifted its position in shares of Sanofi by 18.0% during the third quarter. Creative Planning now owns 220,763 shares of the company’s stock worth $12,723,000 after acquiring an additional 33,728 shares in the last quarter. Regatta Capital Group LLC grew its position in shares of Sanofi by 1.7% in the third quarter. Regatta Capital Group LLC now owns 16,611 shares of the company’s stock valued at $957,000 after purchasing an additional 274 shares in the last quarter. Finally, Asset Dedication LLC raised its stake in shares of Sanofi by 284.1% during the 3rd quarter. Asset Dedication LLC now owns 3,902 shares of the company’s stock valued at $225,000 after purchasing an additional 2,886 shares during the period. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on SNY. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $60.00.

Sanofi Stock Up 1.2 %

Shares of SNY opened at $54.56 on Thursday. The firm has a market cap of $138.46 billion, a P/E ratio of 21.91, a P/E/G ratio of 0.99 and a beta of 0.57. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The stock has a 50 day simple moving average of $50.07 and a two-hundred day simple moving average of $52.41. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 0.74.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.58%. On average, analysts forecast that Sanofi will post 4.36 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.